3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations. By leveraging the power of the immune system to recognize, target, and destroy cancer cells, 3T's technology is adva...See more
Headquarter United States of America |
Year founded 2017 (7 years) |
Funding status Series A |
Company type SME |
Interim CEO
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Interim CEO | hidden.item | hidden.item | hidden.item |